Robotic‐assisted partial cystectomy for muscle invasive bladder cancer: Contemporary experience

Abstract

OBJECTIVE: To report our contemporary experience with robotic-assisted partial cystectomy (RAPC) for muscle invasive bladder cancer. METHODS: This is a retrospective review of patients who underwent robotic-assisted partial cystectomy with us between 2013 and 2020 and provided ≥12 months of follow up. RESULTS AND LIMITATIONS: The median operative time for our 35 patients was 190 min (Interquartile range [IQR] 155-280). Four patients developed grade 3 or higher complications (ileus, pneumonia, and urethral stricture). At 12 months follow-up, the median IPSS score was 10 (IQR 7-11), and recurrence happened in seven patients (recurrence-free survival 80%). Five of the patients who developed recurrence died because of their disease, and two other patients died of causes unrelated to their cancer. CONCLUSIONS: We describe our technique, functional outcomes, and short-term follow up results in highly selected patients with muscle-invasive bladder cancer treated with RAPC.